15 March 2021 - Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.

For around two decades, Roche’s breast cancer drug Herceptin has prolonged the lives of people with breast cancer, and AbbVie’s immunosuppressive drug Humira has eased the symptoms of rheumatoid arthritis patients.

Such are the remarkable benefits of biologic drugs — large molecules that are manufactured using living cells. These kinds of drugs are typically received either in doctors’ offices as an infusion, or self-administered by injection.

Read New York Times article